In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a price target ...
Piper Sandler analyst David Westenberg lowered the firm’s price target on Myriad Genetics (MYGN) to $14 from $24 and keeps a Neutral rating on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback